Your browser doesn't support javascript.
loading
Patient and Provider Characteristics Associated With Sodium-Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease.
McCoy, Ian E; Han, Jialin; Montez-Rath, Maria E; Chertow, Glenn M; Rhee, Jinnie J.
Affiliation
  • McCoy IE; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Han J; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Montez-Rath ME; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Chertow GM; Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
  • Rhee JJ; Stanford Diabetes Research Center, Stanford University School of Medicine, Palo Alto, CA.
Clin Diabetes ; 38(3): 240-247, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32699472
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Clin Diabetes Year: 2020 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: Clin Diabetes Year: 2020 Type: Article Affiliation country: Canada